Acacia Research (NASDAQ:ACTG) Share Price Passes Above Two Hundred Day Moving Average – Should You Sell?

Acacia Research Corporation (NASDAQ:ACTGGet Free Report) crossed above its two hundred day moving average during trading on Thursday . The stock has a two hundred day moving average of $3.62 and traded as high as $4.20. Acacia Research shares last traded at $4.18, with a volume of 195,625 shares trading hands.

Analyst Upgrades and Downgrades

Several equities analysts have recently commented on ACTG shares. Wall Street Zen upgraded Acacia Research from a “hold” rating to a “buy” rating in a research note on Saturday, November 15th. Weiss Ratings reissued a “sell (d)” rating on shares of Acacia Research in a report on Wednesday, January 21st. One research analyst has rated the stock with a Sell rating, Based on data from MarketBeat.com, the company has a consensus rating of “Sell”.

View Our Latest Report on ACTG

Acacia Research Stock Performance

The company has a 50-day moving average of $3.90 and a 200-day moving average of $3.62. The firm has a market capitalization of $403.20 million, a price-to-earnings ratio of 83.62 and a beta of 0.57. The company has a current ratio of 8.63, a quick ratio of 8.11 and a debt-to-equity ratio of 0.16.

Hedge Funds Weigh In On Acacia Research

Large investors have recently bought and sold shares of the business. State Street Corp grew its holdings in shares of Acacia Research by 12.8% during the fourth quarter. State Street Corp now owns 3,145,981 shares of the business services provider’s stock valued at $11,766,000 after purchasing an additional 355,916 shares during the last quarter. Dimensional Fund Advisors LP boosted its position in Acacia Research by 0.4% during the 4th quarter. Dimensional Fund Advisors LP now owns 2,758,800 shares of the business services provider’s stock valued at $10,318,000 after purchasing an additional 10,504 shares during the period. Krilogy Financial LLC grew its stake in Acacia Research by 3.8% during the 4th quarter. Krilogy Financial LLC now owns 1,243,413 shares of the business services provider’s stock worth $4,899,000 after buying an additional 45,015 shares during the last quarter. Levin Capital Strategies L.P. increased its position in Acacia Research by 10.5% in the fourth quarter. Levin Capital Strategies L.P. now owns 983,261 shares of the business services provider’s stock worth $3,677,000 after buying an additional 93,714 shares during the period. Finally, Formidable Asset Management LLC lifted its stake in Acacia Research by 7.0% in the third quarter. Formidable Asset Management LLC now owns 960,355 shares of the business services provider’s stock valued at $3,245,000 after buying an additional 62,625 shares during the last quarter. Institutional investors own 86.69% of the company’s stock.

Acacia Research Company Profile

(Get Free Report)

Acacia Research Corporation is a publicly traded patent licensing company based in New York City. The firm specializes in acquiring patented technologies through a network of wholly owned subsidiaries and seeking licensing agreements or settlements with companies that utilize those technologies. Since its founding in 1993, Acacia has built a business model centered on identifying innovative inventions and monetizing them through patent enforcement and strategic partnerships.

The company’s activities span a broad range of technology sectors, including life sciences, medical devices, software, telecommunications and consumer electronics.

See Also

Receive News & Ratings for Acacia Research Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acacia Research and related companies with MarketBeat.com's FREE daily email newsletter.